Symbols / SLNO Stock $53.01 Soleno Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
SLNO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Anish Bhatnagar M.D.
Exch · Country NCM · United States
Market Cap 2.76B
Enterprise Value 2.56B
Income 95.63M
Sales 285.01M
FCF (ttm) 91.67M
Book/sh 8.61
Cash/sh 4.90
Employees 182
Insider 10d —
IPO Nov 13, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 27.47
Forward P/E -23.35
PEG —
P/S 9.69
P/B 6.16
P/C —
EV/EBITDA 27.99
EV/Sales 8.99
Quick Ratio 5.21
Current Ratio 5.62
Debt/Eq 10.95
LT Debt/Eq —
EPS (ttm) 1.93
EPS next Y -2.27
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-07
ROA 12.07%
ROE 26.38%
ROIC —
Gross Margin 98.63%
Oper. Margin 33.57%
Profit Margin 33.70%
Shs Outstand 52.12M
Shs Float 51.46M
Insider Own 1.31%
Instit Own 111.53%
Short Float 17.89%
Short Ratio 1.01
Short Interest 6.53M
52W High 90.32
vs 52W High -41.31%
52W Low 29.43
vs 52W Low 80.12%
Beta -2.22
Impl. Vol. —
Rel Volume 1.37
Avg Volume 3.62M
Volume 4.97M
Target (mean) $53.00
Tgt Median $53.00
Tgt Low $53.00
Tgt High $53.00
# Analysts 5
Recom Hold
Prev Close $0.00
Price $53.01
Change —
About

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$53.00
Mean price target
2. Current target
$53.01
Latest analyst target
3. DCF / Fair value
$31.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$53.01
Low
$53.00
High
$53.00
Mean
$53.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-17 down Wells Fargo Overweight → Equal-Weight $53
2026-04-08 down HC Wainwright & Co. Buy → Neutral $53
2026-04-07 down TD Cowen Buy → Hold $53
2026-04-07 down Wolfe Research Outperform → Peer Perform —
2026-04-06 down Cantor Fitzgerald Overweight → Neutral $53
2026-03-18 main Oppenheimer Outperform → Outperform $80
2026-03-04 main HC Wainwright & Co. Buy → Buy $100
2026-02-27 main Wells Fargo Overweight → Overweight $110
2026-02-26 main TD Cowen Buy → Buy $85
2026-01-20 main Wells Fargo Overweight → Overweight $114
2026-01-20 main HC Wainwright & Co. Buy → Buy $120
2025-11-18 init Wolfe Research — → Outperform $75
2025-11-05 main Wells Fargo Overweight → Overweight $106
2025-08-27 reit Guggenheim Buy → Buy $106
2025-08-20 init Wells Fargo — → Overweight $123
2025-08-18 main HC Wainwright & Co. Buy → Buy $110
2025-08-07 main Guggenheim Buy → Buy $106
2025-08-07 main Oppenheimer Outperform → Outperform $110
2025-07-11 main Baird Outperform → Outperform $121
2025-05-08 main Guggenheim Buy → Buy $97
News
RSS: Latest SLNO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-27 MANNING MEREDITH S. Officer — 7,522 $30.04 $228,980
2026-03-27 HUANG MICHAEL F Officer — 6,582 $30.04 $200,365
2026-03-02 FULK JENNIFER Chief Financial Officer — 67,660 $39.06 $2,642,800
2026-03-02 FULK JENNIFER Chief Financial Officer — 39,200 $0.00 $0
2026-01-21 YEN KRISTEN Officer — 10,400 $0.00 $0
2026-01-21 MANNING MEREDITH S. Officer — 28,600 $0.00 $0
2026-01-21 HIRANO PATRICIA C Officer — 10,400 $0.00 $0
2026-01-21 NORRETT KEVIN Officer — 3,500 $0.00 $0
2026-01-21 JOSHI MANHER Officer — 4,100 $0.00 $0
2026-01-21 HUANG MICHAEL F Officer — 10,400 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
190.41
0.00
0.00
0.00
Operating Revenue
190.41
0.00
0.00
0.00
Cost Of Revenue
2.70
0.00
0.00
—
Reconciled Cost Of Revenue
2.70
0.00
0.00
—
Gross Profit
187.71
0.00
0.00
—
Operating Expense
172.75
-6.33%
184.43
+376.93%
38.67
+54.01%
25.11
Research And Development
40.63
-48.29%
78.57
+211.91%
25.19
+65.01%
15.27
Selling General And Administration
132.13
+24.81%
105.86
+685.26%
13.48
+36.95%
9.84
General And Administrative Expense
—
105.86
+685.26%
13.48
+36.95%
9.84
Other Gand A
—
105.86
+685.26%
13.48
+36.95%
9.84
Total Expenses
175.46
-4.87%
184.43
+376.93%
38.67
+54.01%
25.11
Operating Income
14.95
+108.11%
-184.43
-376.93%
-38.67
-54.01%
-25.11
Total Operating Income As Reported
9.41
+105.02%
-187.67
-353.49%
-41.38
-69.63%
-24.40
EBITDA
28.38
+116.35%
-173.63
-368.90%
-37.03
-67.53%
-22.10
Normalized EBITDA
33.92
+119.91%
-170.39
-399.18%
-34.13
-49.42%
-22.84
Reconciled Depreciation
2.02
+1.51%
1.99
+1.48%
1.96
-0.31%
1.96
EBIT
26.37
+115.01%
-175.62
-350.44%
-38.99
-62.00%
-24.07
Total Unusual Items
-5.54
-70.76%
-3.24
-11.95%
-2.90
-490.30%
0.74
Total Unusual Items Excluding Goodwill
-5.54
-70.76%
-3.24
-11.95%
-2.90
-490.30%
0.74
Special Income Charges
-5.54
-70.76%
-3.24
-19.45%
-2.71
-481.18%
0.71
Restructuring And Mergern Acquisition
5.54
+70.76%
3.24
+19.45%
2.71
+481.18%
-0.71
Net Income
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Pretax Income
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Net Non Operating Interest Income Expense
11.48
-2.92%
11.82
+358.53%
2.58
+759.33%
0.30
Interest Expense Non Operating
5.48
+2270.56%
0.23
0.00
0.00
Net Interest Income
11.48
-2.92%
11.82
+358.53%
2.58
+759.33%
0.30
Interest Expense
5.48
+2270.56%
0.23
0.00
0.00
Interest Income Non Operating
16.95
+40.66%
12.05
+367.49%
2.58
+759.33%
0.30
Interest Income
16.95
+40.66%
12.05
+367.49%
2.58
+759.33%
0.30
Other Income Expense
-5.54
-70.76%
-3.24
-11.95%
-2.90
-490.30%
0.74
Gain On Sale Of Security
—
—
-0.18
-706.67%
0.03
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Net Income From Continuing Operation Net Minority Interest
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Net Income From Continuing And Discontinued Operation
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Net Income Continuous Operations
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Normalized Income
26.43
+115.31%
-172.61
-378.24%
-36.09
-45.48%
-24.81
Net Income Common Stockholders
20.48
+111.64%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Otherunder Preferred Stock Dividend
0.41
0.00
0.00
—
Diluted EPS
0.39
+108.90%
-4.38
-85.59%
-2.36
+17.77%
-2.87
Basic EPS
0.40
+109.13%
-4.38
-85.59%
-2.36
+17.77%
-2.87
Basic Average Shares
50.82
+26.49%
40.18
+143.61%
16.49
+96.40%
8.40
Diluted Average Shares
52.38
+30.39%
40.18
+143.61%
16.49
+96.40%
8.40
Diluted NI Availto Com Stockholders
20.48
+111.64%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
563.83
+70.36%
330.97
+83.17%
180.69
+581.93%
26.50
Current Assets
355.81
+21.07%
293.89
+71.51%
171.36
+995.15%
15.65
Cash Cash Equivalents And Short Term Investments
305.47
+4.82%
291.44
+71.76%
169.68
+1062.04%
14.60
Cash And Cash Equivalents
70.11
-20.27%
87.93
-48.18%
169.68
+1062.04%
14.60
Other Short Term Investments
235.37
+15.65%
203.51
0.00
—
Receivables
28.21
0.00
—
—
Accounts Receivable
28.21
0.00
—
—
Inventory
15.02
0.00
—
—
Raw Materials
6.45
0.00
—
—
Work In Process
2.71
0.00
—
—
Finished Goods
6.02
0.00
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
7.11
+189.97%
2.45
+46.21%
1.68
+60.48%
1.04
Total Non Current Assets
208.02
+460.95%
37.08
+297.33%
9.33
-13.98%
10.85
Net PPE
2.38
-20.38%
2.98
+612.17%
0.42
+166.88%
0.16
Gross PPE
2.50
-18.17%
3.05
+501.18%
0.51
+118.97%
0.23
Accumulated Depreciation
-0.12
-75.71%
-0.07
+21.35%
-0.09
-18.67%
-0.07
Properties
0.00
0.00
0.00
—
Machinery Furniture Equipment
0.21
+5.39%
0.20
+101.98%
0.10
+0.00%
0.10
Other Properties
2.19
-21.69%
2.80
+587.47%
0.41
+210.69%
0.13
Leases
0.09
+78.85%
0.05
0.00
—
Goodwill And Other Intangible Assets
4.86
-28.57%
6.80
-22.22%
8.75
-18.18%
10.69
Other Intangible Assets
4.86
-28.57%
6.80
-22.22%
8.75
-18.18%
10.69
Investments And Advances
200.62
+637.26%
27.21
0.00
—
Other Non Current Assets
0.16
+96.39%
0.08
-49.70%
0.17
—
Total Liabilities Net Minority Interest
113.72
+32.44%
85.86
+270.34%
23.18
+43.56%
16.15
Current Liabilities
61.36
+227.32%
18.75
+62.95%
11.51
+57.32%
7.31
Payables And Accrued Expenses
16.55
+23.09%
13.45
+105.52%
6.54
+30.87%
5.00
Payables
12.44
+40.00%
8.88
+182.06%
3.15
+77.21%
1.78
Accounts Payable
12.44
+40.00%
8.88
+182.06%
3.15
+77.21%
1.78
Current Accrued Expenses
4.11
-9.84%
4.56
+34.48%
3.39
+5.31%
3.22
Pensionand Other Post Retirement Benefit Plans Current
9.68
+102.62%
4.78
+52.34%
3.13
+87.16%
1.68
Current Debt And Capital Lease Obligation
0.73
+38.02%
0.53
+92.67%
0.27
+76.13%
0.15
Current Capital Lease Obligation
0.73
+38.02%
0.53
+92.67%
0.27
+76.13%
0.15
Other Current Liabilities
20.38
+644.61%
2.74
+76.01%
1.55
+221.28%
0.48
Total Non Current Liabilities Net Minority Interest
52.35
-21.99%
67.11
+474.64%
11.68
+32.18%
8.84
Long Term Debt And Capital Lease Obligation
51.83
-0.90%
52.30
+40130.77%
0.13
0.00
Long Term Debt
49.86
+0.07%
49.83
—
—
Long Term Capital Lease Obligation
1.96
-20.55%
2.47
+1801.54%
0.13
0.00
Other Non Current Liabilities
0.53
-96.46%
14.81
+28.25%
11.55
+30.72%
8.84
Stockholders Equity
450.12
+83.64%
245.11
+55.62%
157.51
+1422.10%
10.35
Common Stock Equity
450.12
+83.64%
245.11
+55.62%
157.51
+1422.10%
10.35
Capital Stock
0.05
+13.04%
0.05
+43.75%
0.03
+300.00%
0.01
Common Stock
0.05
+13.04%
0.05
+43.75%
0.03
+300.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
52.29
+14.40%
45.70
+44.28%
31.68
+288.24%
8.16
Ordinary Shares Number
52.29
+14.40%
45.70
+44.28%
31.68
+288.24%
8.16
Additional Paid In Capital
881.02
+26.41%
696.97
+60.63%
433.88
+75.12%
247.76
Retained Earnings
-431.37
+4.62%
-452.26
-63.62%
-276.41
-16.42%
-237.42
Gains Losses Not Affecting Retained Earnings
0.41
+14.96%
0.36
0.00
—
Other Equity Adjustments
0.41
+14.96%
0.36
—
—
Total Equity Gross Minority Interest
450.12
+83.64%
245.11
+55.62%
157.51
+1422.10%
10.35
Total Capitalization
499.98
+69.52%
294.94
+87.26%
157.51
+1422.10%
10.35
Working Capital
294.45
+7.02%
275.14
+72.12%
159.85
+1818.08%
8.33
Invested Capital
499.98
+69.52%
294.94
+87.26%
157.51
+1422.10%
10.35
Total Debt
52.55
-0.52%
52.83
+13008.19%
0.40
+160.00%
0.15
Capital Lease Obligations
2.69
-10.27%
3.00
+643.92%
0.40
+160.00%
0.15
Net Tangible Assets
445.25
+86.84%
238.31
+60.20%
148.76
+43218.26%
-0.34
Tangible Book Value
445.25
+86.84%
238.31
+60.20%
148.76
+43218.26%
-0.34
Available For Sale Securities
200.62
+637.26%
27.21
—
—
Current Provisions
14.03
—
—
—
Derivative Product Liabilities
—
—
0.00
-100.00%
0.00
Interest Payable
0.40
0.00
—
—
Inventories Adjustments Allowances
-0.16
0.00
—
—
Investmentin Financial Assets
200.62
+637.26%
27.21
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
46.80
+167.73%
-69.10
-177.05%
-24.94
-20.01%
-20.78
Cash Flow From Continuing Operating Activities
46.80
+167.73%
-69.10
-177.05%
-24.94
-20.01%
-20.78
Net Income From Continuing Operations
20.89
+111.88%
-175.85
-351.04%
-38.99
-62.00%
-24.07
Depreciation Amortization Depletion
2.02
+1.51%
1.99
+1.48%
1.96
-0.31%
1.96
Depreciation And Amortization
2.02
+1.51%
1.99
+1.48%
1.96
-0.31%
1.96
Other Non Cash Items
6.20
+68.07%
3.69
+21.45%
3.04
+819.19%
-0.42
Stock Based Compensation
45.85
-54.13%
99.96
+1581.38%
5.95
+134.98%
2.53
Operating Gains Losses
—
—
0.18
+706.67%
-0.03
Gain Loss On Investment Securities
—
—
0.18
+706.67%
-0.03
Change In Working Capital
-24.63
-509.32%
6.02
+105.53%
2.93
+487.30%
-0.76
Change In Receivables
-28.21
0.00
0.00
—
Changes In Account Receivables
-28.21
0.00
0.00
—
Change In Inventory
-14.03
0.00
0.00
—
Change In Prepaid Assets
-4.74
-531.73%
-0.75
+10.39%
-0.84
-840.71%
0.11
Change In Payables And Accrued Expense
8.51
+16.41%
7.31
+158.23%
2.83
+489.01%
-0.73
Change In Accrued Expense
4.90
+198.66%
1.64
+12.40%
1.46
+94.93%
0.75
Change In Payable
3.61
-36.32%
5.67
+313.41%
1.37
+192.89%
-1.48
Change In Account Payable
3.61
-36.32%
5.67
+313.41%
1.37
+192.89%
-1.48
Change In Other Working Capital
—
—
1.46
+54.17%
0.95
Change In Other Current Liabilities
13.83
+2637.80%
-0.55
-158.41%
0.93
+761.70%
-0.14
Investing Cash Flow
-201.78
+10.59%
-225.68
0.00
+100.00%
-0.01
Cash Flow From Continuing Investing Activities
-201.78
+10.59%
-225.68
0.00
+100.00%
-0.01
Net PPE Purchase And Sale
-0.07
+66.51%
-0.22
0.00
+100.00%
-0.01
Purchase Of PPE
-0.07
+66.51%
-0.22
0.00
+100.00%
-0.01
Capital Expenditure
-0.07
+66.51%
-0.22
—
-0.01
Net Investment Purchase And Sale
-201.71
+10.54%
-225.46
0.00
0.00
Purchase Of Investment
-455.78
-27.86%
-356.46
0.00
0.00
Sale Of Investment
254.07
+93.95%
131.00
0.00
0.00
Financing Cash Flow
137.16
-35.61%
213.03
+18.33%
180.02
+1177.46%
14.09
Cash Flow From Continuing Financing Activities
137.16
-35.61%
213.03
+18.33%
180.02
+1177.46%
14.09
Net Issuance Payments Of Debt
0.00
-100.00%
49.89
0.00
0.00
Issuance Of Debt
0.00
-100.00%
49.89
0.00
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
0.00
-100.00%
49.89
0.00
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
0.00
-100.00%
49.89
0.00
0.00
Net Common Stock Issuance
115.58
-22.41%
148.96
+8.05%
137.86
+877.15%
14.11
Common Stock Payments
-100.15
0.00
0.00
—
Repurchase Of Capital Stock
-100.15
0.00
0.00
—
Proceeds From Stock Option Exercised
22.39
+57.87%
14.18
-66.36%
42.16
0.00
Net Other Financing Charges
-0.80
—
—
-0.02
Changes In Cash
-17.82
+78.20%
-81.75
-152.72%
155.08
+2413.92%
-6.70
Beginning Cash Position
87.93
-48.18%
169.68
+1062.04%
14.60
-31.46%
21.30
End Cash Position
70.11
-20.27%
87.93
-48.18%
169.68
+1062.04%
14.60
Free Cash Flow
46.73
+167.41%
-69.31
-177.92%
-24.94
-19.94%
-20.79
Interest Paid Supplemental Data
4.53
+2069.38%
0.21
0.00
—
Amortization Of Securities
-3.52
+28.15%
-4.89
0.00
0.00
Common Stock Issuance
215.72
+44.82%
148.96
+8.05%
137.86
+877.15%
14.11
Issuance Of Capital Stock
215.72
+44.82%
148.96
+8.05%
137.86
+877.15%
14.11
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category